Vetsfarma Limited - Due diligence report

A 360° intelligence report on Vetsfarma: trust score, financial health, credit view, compliance, directors, growth and distress signals - ge…

1979-07-02 Jalandhar, Punjab Active Unlisted Active Compliant
Connect MCP
VL Vetsfarma Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Vetsfarma — 360° Intelligence Report

Generated from MCA filings & public records
88/100
Trust Score
Low Risk

Vetsfarma is assessed as Low Risk with a Trust Score of 88/100. Vetsfarma is an active public limited indian non-government company incorporated in 1979, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 27 Jul 2026 from the latest processed filings. Vetsfarma Limited snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
88/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
80/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
80/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
90/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 80/100 Low Risk
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 3 open (9.59 cr) · 13 satisfied (1.55 cr).

Banking relationships (from registered charges)
LenderChargesAmount
State Bank Of India6 48.0 cr
Punjab National Bank7 48.0 cr
District Industry Centre1 48.0 cr
Bank Of India2 48.0 cr
Compliance Score: 80/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 3 court forum(s).
  • 2 active GST registration(s).
Legal cases on record (3)
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
ADWAITA TEWARI 01234567 Director 01/04/2018 6 yrs Approved
KULBHUSHAN RAI MADAN 01234567 Director 01/04/2018 6 yrs Approved
USHA TEWARI 01234567 Director 01/04/2018 6 yrs Approved
GAURAV TIWARI 01234567 Director 01/04/2018 6 yrs Approved
SUKARN TIWARI 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: KULBHUSHAN RAI MADAN (Managing Director) · GAURAV TIWARI (Whole-time director) · SUKARN TIWARI (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 90 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Latest year revenue grew 2.1x.
Asset base grew 24% - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 47+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Profit declined two years in a row.
3 open charge(s) registered - assets are encumbered.
3 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence82/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment84/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 3 open charge(s) of 9.59 cr already registered.
  • Compliance record supports lending.
Investor view91/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
08 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
21 Feb 2025
Charge satisfied
State Bank Of India
23 Sep 2024
Director ceased
ADWAITA TEWARI
05 Feb 2024
Director appointed
ADWAITA TEWARI (Director)
30 Dec 2020
Charge created
State Bank Of India - 15.60 Lakh
15 Dec 2020
Charge satisfied
State Bank Of India
04 Jun 2019
Charge created
State Bank Of India - 15.00 Lakh
15 Jun 2018
Charge created
State Bank Of India - 7.80 Lakh
23 Feb 2018
Charge satisfied
State Bank Of India
09 Nov 2015
Director appointed
USHA TEWARI (Director)
25 Mar 2015
Securities allotted
242500.00 Equity Shares - 24.25 Lakh raised
16 Mar 2015
Charge created
State Bank Of India - 8.00 Lakh
08 Jan 2015
Charge satisfied
District Industry Centre
17 Nov 2014
Charge satisfied
Punjab National Bank
10

Key Observations

Auto-generated from the data above
Revenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Debt-to-equity stands at 1.42 - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
5 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Stuck Chemicals Private Limited U24100DL2012PTC239922 New Delhi, Delhi, India
Trimaxbiosciences U24297TG2010PTC068376 Tirumalagiri, Telangana, India
Luxture Surface Coatings Private Limited U24229RJ2007PTC024769 Ajmer, Rajasthan, India
Karrat Chemicals (India) Private Limited U24110MH1991PTC063713 Palghar, Maharashtra, India
Unexolifesciences U85191DL2013PTC259443 New Delhi, Delhi, India
Teknovace Wood Coatings Private Limited U24290PN2018PTC180436 Pune, Maharashtra, India
Nebula Healthcare Limited U74999GJ2018PLC102425 Daskroi, Gujarat, India
Yacca Pharmaceuticals U24231UP1989PTC011458 Uttar Pradesh, Uttar Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Vetsfarma before audits and certifications: compliance score 80/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Vetsfarma: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 80/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 90/100, margin trends, ownership structure and peer set for Vetsfarma - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 88/100, distress signals and MSME payment-delay disclosures - know whether Vetsfarma pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Vetsfarma - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Vetsfarma an active company?

Vetsfarma has MCA status “Active” with a compliance score of 80/100 (Low Risk).

Is Vetsfarma financially healthy?

Vetsfarma has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Vetsfarma?

Its overall Trust Score is 88/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Vetsfarma?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 5 active director(s) are on record.

Does Vetsfarma have loans or charges against its assets?

3 open charge(s) are registered against its assets, and 13 earlier charge(s) stand satisfied.

Is Vetsfarma up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 80/100 (Low Risk).

Is it risky to lend to Vetsfarma?

Its Credit Risk Score is 80/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.